December 2017 - Volume 43 - Supplement 3
pp: S243-S372

Comparing Injectable DaxibotulinumtoxinA and OnabotulinumtoxinA in Moderate and Severe Glabellar Lines: Additional Analyses From a Phase 2, Randomized, Dose-Ranging, Double-Blind, Multicenter Study

Bertucci, Vince; Humphrey, Shannon; Carruthers, Jean; More

Dermatologic Surgery. 43:S262-S273, December 2017.

IncobotulinumtoxinA Is an Effective and Well-Tolerated Treatment for Upper Facial Lines: Results From an Open-Label Extension Period of a Phase III Study

Trevidic, Patrick; Connolly, Simon A.; Biwer, Bernard; More

Dermatologic Surgery. 43:S285-S292, December 2017.